AstraZeneca's Imfinzi Achieves Positive Results in Phase 3 Trial

Date : 10/28/2019 @ 4:20PM
Source : Dow Jones News
Stock : Astrazeneca Plc (AZN)
Quote : 7659.0  2.0 (0.03%) @ 4:35PM
Astrazeneca share price Chart

AstraZeneca's Imfinzi Achieves Positive Results in Phase 3 Trial

Astrazeneca (LSE:AZN)
Historical Stock Chart

3 Months : From Oct 2019 to Jan 2020

Click Here for more Astrazeneca Charts.
   By Adria Calatayud 
 

AstraZeneca PLC (AZN.LN) said Monday that its Imfinzi drug achieved positive results in a phase 3 trial in previously-untreated metastatic non-small cell lung cancer.

The U.K. pharmaceutical company said the trial met a primary endpoint by showing a statistically significant and clinically meaningful improvement in the final progression-free survival analysis in patients treated with a combination of Imfinzi and five standard-of-care platinum-based chemotherapy options versus chemotherapy alone.

The triple combination of Imfinzi plus tremelimumab and chemotherapy also demonstrated a statistically significant and clinically meaningful PFS improvement versus chemotherapy alone as a key secondary endpoint, AstraZeneca said.

The company said both Imfinzi and Imfinzi plus tremelimumab delayed disease progression in a phase 3 study for first-line treatment of metastatic non-small cell lung cancer.

The trial will continue to assess the additional primary endpoint of overall survival with data anticipated in 2020, AstraZeneca said.

Shares in London at 1544 GMT were up 2.1% at 7,536 pence.

 

Write to Adria Calatayud at adria.calatayudvaello@dowjones.com

 

(END) Dow Jones Newswires

October 28, 2019 12:05 ET (16:05 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200126 15:34:24